| For: | Khan SA, Reddy D, Gupta S. Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? World J Biol Chem 2015; 6(4): 333-345 [PMID: 26629316 DOI: 10.4331/wjbc.v6.i4.333] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v6/i4/333.htm |
| Number | Citing Articles |
| 1 |
Debashis Roy Chowdhury, Debanjan Sen, Sagnik Jyoti Roy, Swapan Majumdar, Sudhan Debnath. Discovery of Potential Selective HDAC8 Binders: Using Combination of Pharmacophore‐Based–Structure‐Based Virtual Screening, ADME Filtration, and Molecular Dynamics Studies. ChemistrySelect 2025; 10(15) doi: 10.1002/slct.202500646
|
| 2 |
Xiaoping Zhang, Yong Zhong, Lin Liu, Chengyou Jia, Haidong Cai, Jianshe Yang, Bo Wu, Zhongwei Lv. Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma. Cell Death & Disease 2023; 14(12) doi: 10.1038/s41419-023-06348-0
|
| 3 |
Khayelihle B. Makhathini, Oualid Abboussi, Dan J. Stein, Musa V. Mabandla, William M.U. Daniels. Repetitive stress leads to impaired cognitive function that is associated with DNA hypomethylation, reduced BDNF and a dysregulated HPA axis. International Journal of Developmental Neuroscience 2017; 60(1) doi: 10.1016/j.ijdevneu.2017.04.004
|
| 4 |
Angelo Agnusdei, Adrián González-García, Donato Gerin, Stefania Pollastro, Francesco Faretra, Luis González-Candelas, Ana-Rosa Ballester. Histone Methyltransferases AcDot1 and AcRmtA Are Involved in Growth Regulation, Secondary Metabolism, and Stress Response in Aspergillus carbonarius. Toxins 2025; 17(4) doi: 10.3390/toxins17040196
|
| 5 |
Daniel Desaulniers, Cathy Cummings-Lorbetskie, Nanqin Li, Gong-Hua Xiao, Leonora Marro, Nasrin Khan, Karen Leingartner. Sodium bisulfite pyrosequencing revealed that developmental exposure to environmental contaminant mixtures does not affect DNA methylation of DNA repeats in Sprague-Dawley rats. Journal of Toxicology and Environmental Health, Part A 2017; 80(1) doi: 10.1080/15287394.2016.1231644
|
| 6 |
Sanket G. Shah, Tushar Mandloi, Pooja Kunte, Abhiram Natu, Mudasir Rashid, Divya Reddy, Nikhil Gadewal, Sanjay Gupta. HISTome2: a database of histone proteins, modifiers for multiple organisms and epidrugs. Epigenetics & Chromatin 2020; 13(1) doi: 10.1186/s13072-020-00354-8
|
| 7 |
Elena G. Pasyukova, Alexander V. Symonenko, Olga Y. Rybina, Alexander M. Vaiserman. Epigenetic enzymes: A role in aging and prospects for pharmacological targeting. Ageing Research Reviews 2021; 67 doi: 10.1016/j.arr.2021.101312
|
| 8 |
Peter Kubatka, Martin Kello, Karol Kajo, Marek Samec, Karin Jasek, Desanka Vybohova, Sona Uramova, Alena Liskova, Vladimira Sadlonova, Lenka Koklesova, Radovan Murin, Marian Adamkov, Karel Smejkal, Emil Svajdlenka, Peter Solar, Samson Mathews Samuel, Monika Kassayova, Taeg Kyu Kwon, Pavol Zubor, Martin Pec, Jan Danko, Dietrich Büsselberg, Jan Mojzis. Chemopreventive and Therapeutic Efficacy of Cinnamomum zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro Analyses. Molecules 2020; 25(6) doi: 10.3390/molecules25061399
|
| 9 |
Daoyin Dong, E. Albert Reece, Peixin Yang. Handbook of Nutrition, Diet, and Epigenetics. 2019; doi: 10.1007/978-3-319-55530-0_101
|
| 10 |
Yanqi Sang, Yu Deng. Current insights into the epigenetic mechanisms of skin cancer. Dermatologic Therapy 2019; doi: 10.1111/dth.12964
|
| 11 |
Hongjuan Chai, Chunpeng Pan, Mingyang Zhang, Haizhong Huo, Haiyan Shan, Jugang Wu. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10573-3
|
| 12 |
Lyudmila F. Gulyaeva, Nicolay E. Kushlinskiy. Regulatory mechanisms of microRNA expression. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-0893-x
|
| 13 |
Azadeh Shahidian, Majid Ghassemi, Javad Mohammadi, Mohadeseh Hashemi. Bio-Engineering Approaches to Cancer Diagnosis and Treatment. 2020; doi: 10.1016/B978-0-12-817809-6.00003-0
|
| 14 |
Md. Fazlul Karim, Yearul Kabir. Handbook of Cancer and Immunology. 2023; doi: 10.1007/978-3-030-80962-1_50-1
|
| 15 |
Madhumati Bora, Pratibha Parihar. Anticancer Plants: Mechanisms and Molecular Interactions. 2018; doi: 10.1007/978-981-10-8417-1_1
|
| 16 |
Ali Alavian‐Ghavanini, Joëlle Rüegg. Understanding Epigenetic Effects of Endocrine Disrupting Chemicals: From Mechanisms to Novel Test Methods. Basic & Clinical Pharmacology & Toxicology 2018; 122(1) doi: 10.1111/bcpt.12878
|
| 17 |
Masahiro Mimura, Hiroka Sugai, Tomoshi Kameda, Ryo Kitahara, Soichiro Kitazawa, Yoichi Shinkai, Sayaka Ishihara, Ryoji Kurita, Shunsuke Tomita. Proximity of the Histone-Acetylation Site to the Termini Shapes Phase Behavior with DNA. Journal of the American Chemical Society 2026; 148(19) doi: 10.1021/jacs.6c02267
|
| 18 |
Jugang Wu, Hongjuan Chai, Feng Li, Qing Ren, Yan Gu. SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma. Life Sciences 2020; 260 doi: 10.1016/j.lfs.2020.118406
|
| 19 |
Tiziana Bonaldi, Roberta Noberini. Recent advances in mass spectrometry analysis of histone post-translational modifications: potential clinical impact of the PAT-H-MS approach. Expert Review of Proteomics 2016; 13(3) doi: 10.1586/14789450.2016.1147960
|
| 20 |
Hong Wang, Manhua Cui, Shuangli Zhang, Jie He, Li Song, Ying Chen. Relationship between RAS Association Domain Family Protein 1A Promoter Methylation and the Clinicopathological Characteristics in Patients with Ovarian Cancer: A Systematic Meta-Analysis. Gynecologic and Obstetric Investigation 2018; 83(4) doi: 10.1159/000484245
|
| 21 |
Qiang Wang, Bing Wang, Yun-mei Zhang, Wei Wang. The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis. Journal of Ovarian Research 2016; 9(1) doi: 10.1186/s13048-016-0231-1
|
| 22 |
Tayaba Ismail, Hyun-Kyung Lee, Chowon Kim, Taejoon Kwon, Tae Joo Park, Hyun-Shik Lee. KDM1A microenvironment, its oncogenic potential, and therapeutic significance. Epigenetics & Chromatin 2018; 11(1) doi: 10.1186/s13072-018-0203-3
|
| 23 |
Franziska Singer, Anja Irmisch, Nora C. Toussaint, Linda Grob, Jochen Singer, Thomas Thurnherr, Niko Beerenwinkel, Mitchell P. Levesque, Reinhard Dummer, Luca Quagliata, Sacha I. Rothschild, Andreas Wicki, Christian Beisel, Daniel J. Stekhoven. SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics. BMC Medical Informatics and Decision Making 2018; 18(1) doi: 10.1186/s12911-018-0680-0
|
| 24 |
Yunhao Yang, Nanzhi Luo, Zhipeng Gong, Wenjing Zhou, Yin Ku, Yaohui Chen. Lactate and lysine lactylation of histone regulate transcription in cancer. Heliyon 2024; 10(21) doi: 10.1016/j.heliyon.2024.e38426
|
| 25 |
Wan-Ju Tsai, Wu-Shiun Hsieh, Pau-Chung Chen, Chen-Yu Liu. Prenatal Perfluoroalkyl Substance Exposure in Association with Global Histone Post-Translational Methylation in 2-Year-Old Children. Toxics 2024; 12(12) doi: 10.3390/toxics12120876
|
| 26 |
|
| 27 |
Divya Reddy, Bharat Khade, Riddhi Pandya, Sanjay Gupta. A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours. Clinical Epigenetics 2017; 9(1) doi: 10.1186/s13148-017-0330-x
|
| 28 |
Daoyin Dong, E. Albert Reece, Peixin Yang. Handbook of Nutrition, Diet, and Epigenetics. 2017; doi: 10.1007/978-3-319-31143-2_101-1
|
| 29 |
Guanyuan Liu.
CDH1
Promoter Methylation in Patients with Cervical Carcinoma: A Systematic Meta-Analysis with Trial Sequential Analysis
. Future Oncology 2018; 14(1) doi: 10.2217/fon-2017-0267
|
| 30 |
Elena G. Pasyukova, Alexander V. Symonenko, Olga Y. Rybina. Reference Module in Biomedical Sciences. 2019; doi: 10.1016/B978-0-12-801238-3.11298-X
|
| 31 |
Prakriti Sen, Pooja Ganguly, Niladri Ganguly. Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer (Review). Oncology Letters 2017; doi: 10.3892/ol.2017.7292
|
| 32 |
Zipei Cao, Lijuan Wei, Weizhi Zhu, Xuping Yao. Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA). Medicine 2018; 97(12) doi: 10.1097/MD.0000000000010182
|
| 33 |
Giulia Robusti, Alessandro Vai, Tiziana Bonaldi, Roberta Noberini. Investigating pathological epigenetic aberrations by epi-proteomics. Clinical Epigenetics 2022; 14(1) doi: 10.1186/s13148-022-01371-y
|
| 34 |
Hitoshi Aihara, Takeya Nakagawa, Hirofumi Mizusaki, Mitsuhiro Yoneda, Masanori Kato, Masamichi Doiguchi, Yuko Imamura, Miki Higashi, Tsuyoshi Ikura, Tomonori Hayashi, Yoshiaki Kodama, Masaya Oki, Toshiyuki Nakayama, Edwin Cheung, Hiroyuki Aburatani, Ken-ichi Takayama, Haruhiko Koseki, Satoshi Inoue, Yukio Takeshima, Takashi Ito. Histone H2A T120 Phosphorylation Promotes Oncogenic Transformation via Upregulation of Cyclin D1. Molecular Cell 2016; 64(1) doi: 10.1016/j.molcel.2016.09.012
|
| 35 |
|
| 36 |
Cheng Chen, Ying Zhu, Haibo Zhang, Lan Xiao. Prognostic Effects of RASSF1A, BRCA1, APC, and p16 Promoter Methylation in Ovarian Cancer: A Meta-Analysis. Gynecologic and Obstetric Investigation 2024; 89(5) doi: 10.1159/000538673
|
| 37 |
Xianneng Sheng, Yu Guo, Yang Lu. Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer. Medicine 2017; 96(28) doi: 10.1097/MD.0000000000007476
|
| 38 |
Alessandro Vai, Roberta Noberini, Chiara Ghirardi, Dieggo Rodrigues de Paula, Michele Carminati, Rani Pallavi, Nathália Araújo, Patrick Varga-Weisz, Tiziana Bonaldi. Improved Mass Spectrometry–Based Methods Reveal Abundant Propionylation and Tissue-Specific Histone Propionylation Profiles. Molecular & Cellular Proteomics 2024; 23(7) doi: 10.1016/j.mcpro.2024.100799
|
| 39 |
Huayue Cong, Xiaoqiang Guo, Bo Fan, Yingzi Liu, Changzheng Dong, Aixia Sui. Dimethylation of histone H3 lysine 36 (H3K36me2) as a potential biomarker for glioma diagnosis, grading, and prognosis. Journal of Neuropathology & Experimental Neurology 2023; 82(5) doi: 10.1093/jnen/nlad016
|
| 40 |
Shahid Banday, Zeenat Farooq, Shabir Ahmad Ganai, Mohammad Altaf. Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias. Clinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00860-2
|
| 41 |
Yi Zhang, Jianhong Ren, Guangzhao Huang, Rurong Wang. Identification of Candidate Histone Lysine Lactylation (Kla)-associated Biomarkers in Lung Adenocarcinoma (LUAD) Via Integrated Bioinformatics Analysis
. International Journal of Clinical Oncology and Cancer Research 2025; 10(2) doi: 10.11648/j.ijcocr.20251002.14
|
| 42 |
Katerina V. Gurova. Chromatin Stability as a Target for Cancer Treatment. BioEssays 2019; 41(1) doi: 10.1002/bies.201800141
|
| 43 |
Chelsea Hughes, Elizabeth A Mojica, Dietmar Kültz, Jason E Podrabsky. Global maintenance of histone post-translational modifications during the transition into anoxia in embryos of the annual killifish Austrofundulus limnaeus
. Environmental Epigenetics 2025; 11(1) doi: 10.1093/eep/dvaf015
|
| 44 |
Marilena Celano, Catia Mio, Marialuisa Sponziello, Antonella Verrienti, Stefania Bulotta, Cosimo Durante, Giuseppe Damante, Diego Russo. Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer. Molecular and Cellular Endocrinology 2018; 469 doi: 10.1016/j.mce.2017.05.036
|
| 45 |
Irfan-ur-Rauf Tak, Fasil Ali, Jehangir Shafi Dar, Aqib Rehman Magray, Bashir A. Ganai, M.Z. Chishti. Protein Modificomics. 2019; doi: 10.1016/B978-0-12-811913-6.00001-1
|
| 46 |
Roberta Noberini, Giulia Robusti, Alessandro Vai, Evelyn Oliva Savoia, Maria Giovanna Jodice, Giovanni Bertalot, Betül Çat, Isabella Pallavicini, Giuseppina Bonizzi, Maria Capra, Claudia Anna Sangalli, Federico Zambelli, Nicola Fusco, Salvatore Pece, Giulio Pavesi, Saverio Minucci, Tiziana Bonaldi. A histone-centric multi-omics study shows that increased H3K4 methylation sustains triple-negative breast cancer phenotypes. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-63745-z
|
| 47 |
Erika Langsfeld, Laimonis A. Laimins. Human Papillomaviruses: Research Priorities for the Next Decade. Trends in Cancer 2016; 2(5) doi: 10.1016/j.trecan.2016.04.001
|
| 48 |
Zhenghui Liu, Yingxue Gao, Xiong Li. Cancer epigenetics and the potential of epigenetic drugs for treating solid tumors. Expert Review of Anticancer Therapy 2019; 19(2) doi: 10.1080/14737140.2019.1552139
|
| 49 |
Chunyan Shen, Qifang Sheng, Xiaojie Zhang, Yuling Fu, Kemiao Zhu. Hypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancer. Journal of Ovarian Research 2016; 9(1) doi: 10.1186/s13048-016-0271-6
|
| 50 |
Dorota Komar, Przemyslaw Juszczynski. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy. Clinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00941-2
|
| 51 |
Hiwot Tezera Endale, Yitbarek Fantahun Mariye, Habtu Kifle Negash, Fethiya Seid Hassen, Wastina Bitewlign Asrat, Tiget Ayelgn Mengstie, Winta Tesfaye. MiRNA in cervical cancer: Diagnosis to therapy: Systematic review. Heliyon 2024; 10(3) doi: 10.1016/j.heliyon.2024.e24398
|
| 52 |
Shanshan TIAN, Ranran LIU, Xiaolong QIAN, Xiaojing GUO, Kai ZHANG. Extraction and isolation of histones from paraffin-embedded tissues and quantitative analysis of post-translational modifications. Chinese Journal of Chromatography 2021; 39(10) doi: 10.3724/SP.J.1123.2021.06018
|
| 53 |
Roberta Noberini, Rémi Longuespée, Cristina Richichi, Giancarlo Pruneri, Mark Kriegsmann, Giuliana Pelicci, Tiziana Bonaldi. PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples. Clinical Epigenetics 2017; 9(1) doi: 10.1186/s13148-017-0369-8
|
| 54 |
Joanna Szczepanek, Andrzej Tretyn. MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications. Biomolecules 2023; 13(11) doi: 10.3390/biom13111590
|
| 55 |
L Xie, J Hou, H Qi, Y Dai, W She. Histone acetylation in refractory sudden sensorineural hearing loss patients after intratympanic methylprednisolone perfusion. The Journal of Laryngology & Otology 2019; 133(10) doi: 10.1017/S0022215119001865
|
| 56 |
Meng Ye, Tao Huang, Ying Ying, Jinyun Li, Ping Yang, Chao Ni, Chongchang Zhou, Si Chen. Detection of14-3-3 sigma(σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis. Oncotarget 2017; 8(6) doi: 10.18632/oncotarget.13992
|
| 57 |
Raghavendra Vadla, Devyani Haldar. Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation. Cell Cycle 2018; 17(1) doi: 10.1080/15384101.2017.1404207
|
| 58 |
Shumin Ni, Meng Ye, Tao Huang. Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis. Oncotarget 2017; 8(37) doi: 10.18632/oncotarget.18056
|
| 59 |
|
| 60 |
Archismaan Ghosh, Ansuman Lahiri, Sutapa Mukherjee, Madhumita Roy, Amitava Datta. Prevention of inorganic arsenic induced squamous cell carcinoma of the skin in Swiss albino mice by black tea through epigenetic modulation. Heliyon 2022; 8(8) doi: 10.1016/j.heliyon.2022.e10341
|
| 61 |
Madhumitha Kedhari Sundaram, Shefina Silas, Arif Hussain. Epigenetics and Reproductive Health. 2021; doi: 10.1016/B978-0-12-819753-0.00017-9
|
| 62 |
Zhicheng Zhang, Jing‐Jing Hu, Shijun Lin, Jiajun Wu, Fan Xia, Xiaoding Lou. Field effect transistor biosensors for healthcare monitoring. Interdisciplinary Medicine 2024; 2(4) doi: 10.1002/INMD.20240032
|
| 63 |
Md. Fazlul Karim, Yearul Kabir. Cancer Immunology. Handbook of Cancer and Immunology 2025; 1 doi: 10.1007/978-3-032-00749-0_50
|
| 64 |
Lula Smith, Samuel Anti, Natalie White, Sabita N. Saldanha. Epigenetic Mechanisms in Cancer. 2018; doi: 10.1016/B978-0-12-809552-2.00004-8
|
| 65 |
Chunxia Zhu, Xuefeng Feng, Guoliang Ye, Tao Huang. Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guideline. Medicine 2017; 96(16) doi: 10.1097/MD.0000000000006650
|
| 66 |
|
| 67 |
Antja-Voy Hartley, Matthew Martin, Jiamin Jin, Tao Lu. Pharmacoepigenetics. 2019; doi: 10.1016/B978-0-12-813939-4.00037-1
|
| 68 |
Shahin Ramazi, Abdollah Allahverdi, Javad Zahiri. Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disorders. Journal of Biosciences 2020; 45(1) doi: 10.1007/s12038-020-00099-2
|
| 69 |
Angela Mena Perri, Valter Agosti, Erika Olivo, Antonio Concolino, MariaTeresa De Angelis, Laura Tammè, Claudia Vincenza Fiumara, Giovanni Cuda, Domenica Scumaci. Histone proteomics reveals novel post-translational modifications in breast cancer. Aging 2019; 11(23) doi: 10.18632/aging.102577
|
| 70 |
Bashir Lawal, Sung-Hui Tseng, Janet Olugbodi, Sitthichai Iamsaard, Omotayo Ilesanmi, Mohamed Mahmoud, Sahar Ahmed, Gaber Batiha, Alexander Wu. Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance. Cancers 2021; 13(16) doi: 10.3390/cancers13164124
|
| 71 |
Yong Ding, Qihua Yang, Bojun Wang, Guoliang Ye, Xiaoqiong Tong, Aamir Ahmad. The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis. PLOS ONE 2016; 11(11) doi: 10.1371/journal.pone.0165509
|
| 72 |
Yu Zheng, Xia Li, Yiming Jiang, Yufen Xu, Binbin Song, Qiang Zhou, Xiaodong Liang, Xinmei Yang. Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer. Medicine 2016; 95(49) doi: 10.1097/MD.0000000000005433
|
| 73 |
Qinfei Zhao, Weiquan Hu, Jing Xu, Shaoying Zeng, Xuxiang Xi, Jing Chen, Xiangsheng Wu, Suping Hu, Tianyu Zhong. Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.919274
|
| 74 |
Poonam Kumari, Sanjay Kumar Bhadada, Ashutosh Kumar Arya, Jyotdeep Kaur, Naresh Sachdeva, Uma Nahar Saikia, Divya Dahiya, Anoop Kumar, Chirag Kharbanda, Sudhaker D Rao. Aberrant Histone Methylation Profile in Patients with Sporadic Primary Hyperparathyroidism. The Journal of Clinical Endocrinology & Metabolism 2026; 111(6) doi: 10.1210/clinem/dgaf668
|
| 75 |
|
| 76 |
Roshani Sinha, Mai Dvorak, Ananthakrishnan Ganesan, Larry Kalesinskas, Charlotte M. Niemeyer, Christian Flotho, Kathleen M. Sakamoto, Norman Lacayo, Rachana Vinay Patil, Rhonda Perriman, Alma-Martina Cepika, Yunying Lucy Liu, Alex Kuo, Paul J. Utz, Purvesh Khatri, Alice Bertaina. Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape. Cancers 2023; 15(21) doi: 10.3390/cancers15215204
|
| 77 |
Richard A. Stein, Abhi N. Deverakonda. Cancer Research: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 1 doi: 10.1007/16833_2022_86
|
| 78 |
Sreepoorna Pramodh, Ritu Raina, Arif Hussain, Sali Abubaker Bagabir, Shafiul Haque, Syed Tasleem Raza, Mohammad Rehan Ajmal, Shalini Behl, Deepika Bhagavatula. Luteolin Causes 5′CpG Demethylation of the Promoters of TSGs and Modulates the Aberrant Histone Modifications, Restoring the Expression of TSGs in Human Cancer Cells. International Journal of Molecular Sciences 2022; 23(7) doi: 10.3390/ijms23074067
|
| 79 |
Marek Samec, Alena Liskova, Lenka Koklesova, Veronika Mestanova, Maria Franekova, Monika Kassayova, Bianka Bojkova, Sona Uramova, Pavol Zubor, Katarina Janikova, Jan Danko, Samson Samuel, Dietrich Büsselberg, Peter Kubatka. Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin Equilibrium. Biomolecules 2019; 9(12) doi: 10.3390/biom9120829
|
| 80 |
Mariano Colón-Caraballo, Idhaliz Flores-Caldera. Epigenetics in Human Disease. 2024; doi: 10.1016/B978-0-443-21863-7.00008-1
|
| 81 |
Sanga Mitra, Sayak Ganguli, Jayprokas Chakrabarti. Cancer and Noncoding RNAs. 2018; doi: 10.1016/B978-0-12-811022-5.00001-2
|
| 82 |
Trillitye Paullin, Chase Powell, Christopher Menzie, Robert Hill, Feng Cheng, Christopher J. Martyniuk, Sandy D. Westerheide, Surinder K. Batra. Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses. PLOS ONE 2017; 12(8) doi: 10.1371/journal.pone.0182930
|
| 83 |
Qingfeng Guo, Yuming Hua. The assessment of circulating cell-free DNA as a diagnostic tool for breast cancer: an updated systematic review and meta-analysis of quantitative and qualitative ssays. Clinical Chemistry and Laboratory Medicine (CCLM) 2021; 59(9) doi: 10.1515/cclm-2021-0193
|
| 84 |
Priscilla Van den Ackerveken, Clotilde Hannart, Dorian Pamart, Robin Varsebroucq, Marion Wargnies, Olivia Thiry, Marie Lurkin, Séverine Vincent, Muriel Chapelier, Guillaume Rommelaere, Marielle Herzog. High-throughput epigenetic profiling immunoassays for accelerated disease research and clinical development. Journal of Biological Chemistry 2025; 301(7) doi: 10.1016/j.jbc.2025.110352
|
| 85 |
Fatima Domenica Elisa De Palma, Vincent Carbonnier, Francesco Salvatore, Guido Kroemer, Jonathan G. Pol, Maria Chiara Maiuri. Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human Cancers. Cancers 2022; 14(23) doi: 10.3390/cancers14235980
|
| 86 |
Jiann-Jyh Lai, Freidrich M. Cruz, Kenneth L. Rock. Immune Sensing of Cell Death through Recognition of Histone Sequences by C-Type Lectin-Receptor-2d Causes Inflammation and Tissue Injury. Immunity 2020; 52(1) doi: 10.1016/j.immuni.2019.11.013
|
| 87 |
Alireza Nemati, Mohamad Sadegh Aghajanzadeh, Mahdi Rooberahan. An Overview on Cancer Diagnosis based on Antibody-Based Immune Techniques. Modern Medical Laboratory Journal 2020; 3(2) doi: 10.30699/mmlj17.3.1.100
|
| 88 |
Yuting Zhang, Huiting Huang, Libo Jin, Sue Lin. Anticarcinogenic Effects of Isothiocyanates on Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(22) doi: 10.3390/ijms232213834
|
| 89 |
Kamila Romanowska, Agnieszka Sobecka, Agnieszka A. Rawłuszko-Wieczorek, Wiktoria M. Suchorska, Wojciech Golusiński. Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape. Diagnostics 2020; 11(1) doi: 10.3390/diagnostics11010034
|
| 90 |
Mariano Colón-Caraballo, Idhaliz Flores-Caldera. Epigenetics in Human Disease. 2018; doi: 10.1016/B978-0-12-812215-0.00023-6
|
| 91 |
Liang Xia, Wenzhu Zhang, Li Gao. Clinical and prognostic effects ofCDKN2A,CDKN2BandCDH13promoter methylation in ovarian cancer: a study using meta-analysis and TCGA data. Biomarkers 2019; 24(7) doi: 10.1080/1354750X.2019.1652685
|
| 92 |
Yingxue Zhang, Eid Alshammari, Jacob Sobota, Zhe Yang. Genomic and Epigenomic Biomarkers of Toxicology and Disease. 2022; doi: 10.1002/9781119807704.ch13
|
| 93 |
Priscilla Van den Ackerveken, Alison Lobbens, Jean-Valery Turatsinze, Victor Solis-Mezarino, Moritz Völker-Albert, Axel Imhof, Marielle Herzog. A novel proteomics approach to epigenetic profiling of circulating nucleosomes. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86630-3
|
| 94 |
Ashok Kumar, Preeti Maurya, Jeffrey J. Hayes. Post-Translation Modifications and Mutations of Human Linker Histone Subtypes: Their Manifestation in Disease. International Journal of Molecular Sciences 2023; 24(2) doi: 10.3390/ijms24021463
|
| 95 |
Bin Xie, Feng Peng, Fengping He, Yixing Cheng, Jiangtao Cheng, Zhibing Zhou, Wei Mao. DNA methylation influences the CTCF‐modulated transcription of RASSF1A in lung cancer cells. Cell Biology International 2022; 46(11) doi: 10.1002/cbin.11868
|
| 96 |
Anubhav Srivastava, Darren John Creek. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics. PROTEOMICS 2019; 19(10) doi: 10.1002/pmic.201700448
|
| 97 |
Pratibha Pandey, Ali G Alkhathami, Mohd Saeed, Khalid Alshaghdali, Sandeep Kumar, Trina Tallei, Hanul Bae, Moon Nyeo Park, Gaurav Kumar, Bonglee Kim, Fahad Khan. Molecular Insights into Phytochemicals Mediated Epigenetic Regulation in Preclinical Models of Breast Cancer. Drug Design, Development and Therapy 2025; doi: 10.2147/DDDT.S554844
|
| 98 |
Shilpi Sarkar, Dheepika Venkatesh, Thirukumaran Kandasamy, Siddhartha Sankar Ghosh. Epigenetic Modulations in Breast Cancer: An Emerging Paradigm in Therapeutic Implications. Frontiers in Bioscience-Landmark 2024; 29(8) doi: 10.31083/j.fbl2908287
|
| 99 |
Wen-Ting Chu, Jin Wang. Uncovering the lung cancer mechanisms through the chromosome structural ensemble characteristics and nucleation seeds. The Journal of Chemical Physics 2024; 161(22) doi: 10.1063/5.0238929
|
| 100 |
Jugang Wu, Hongjuan Chai, Xin Xu, Jiwei Yu, Yan Gu. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer. Molecular Oncology 2020; 14(6) doi: 10.1002/1878-0261.12689
|
| 101 |
Vladimir Y. Ovchinnikov, Denis V. Antonets, Lyudmila F. Gulyaeva. The search of CAR, AhR, ESRs binding sites in promoters of intronic and intergenic microRNAs. Journal of Bioinformatics and Computational Biology 2018; 16(01) doi: 10.1142/S0219720017500299
|
| 102 |
Roberta Noberini, Giulia Robusti, Tiziana Bonaldi. Mass spectrometry‐based characterization of histones in clinical samples: applications, progress, and challenges. The FEBS Journal 2022; 289(5) doi: 10.1111/febs.15707
|
| 103 |
Jugang Wu, Hongjuan Chai, Haiyan Shan, Chunpeng Pan, Xin Xu, Wenpei Dong, Jiwei Yu, Yan Gu. Histone Methyltransferase SETD1A Induces Epithelial-Mesenchymal Transition to Promote Invasion and Metastasis Through Epigenetic Reprogramming of Snail in Gastric Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.657888
|
| 104 |
Pritha Bhattacharjee, Somnath Paul, Sandip Bhattacharjee, Ashok K. Giri, Pritha Bhattacharjee. Association of H3K79 monomethylation (an epigenetic signature) with arsenic-induced skin lesions. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2018; 807 doi: 10.1016/j.mrfmmm.2017.11.001
|
| 105 |
Minghui Zhang, Bowen Wu, Jinke Gu. The Pivotal Role of LACTB in the Process of Cancer Development. International Journal of Molecular Sciences 2025; 26(3) doi: 10.3390/ijms26031279
|